ADAMTSL5 and lung carcinoma: Besides melanoma, ADAMTSL5-specific immune responses could also be induced in other cancer types, being ADAMTSL5 dysregulated in a wide variety of malignant tumors, including lung cancer and hepatocarcinoma (28, 45).